Health

Researcher Charles Nichols Studies the Impact of Psychedelic Substances on Inflammation

Critical research sponsored by the Eleusis Benefit Corporation could lead to new drugs for Alzeimers and Retinal Disease.

MindMed Announces New Technology that Optimizes Psychedelic Dosing

The company is developing a technology that seeks to personalize psychedelic therapy experiences for patients.

How LSD Can Help Manage Autistic Sensory Issues

In this video interview, Orsini describes how he used LSD to help treat his own autism, and what he’s doing to increase awareness for psychedelic-assisted approaches to treating autism.

MAPS Announces Findings from Phase 2 MDMA Clinical Trials for PTSD

The benefits of MDMA-assisted psychotherapy appear to grow over time, but the study lacks racial diversity.

Our Country Is in Fight or Flight, Says Psychiatrist Julie Holland

The psychiatrist and psychedelics expert Julie Holland discusses why human connection is important for both physical wellbeing and for the body politic in her new book, Good Chemistry.

New Study Shows How DMT Refreshes Perceptions

Research reveals how DMT affects brain waves to give rise to visionary experiences.

Silo Wellness Offers Free Psilocybin Retreat for Covid-19 Frontline Workers

The Oregon-based startup is taking applications from healthcare workers to receive psychedelic-assisted therapy at a Jamaican retreat center. Will they be ready?

Groundbreaking Model Reveals New Insights about Psilocybin’s Effect on the Brain

Scientists get closer to understanding why psychedelics show promise for treating mental illness.

Utah Clinician Exemplifies Innovation in Ketamine Therapy

SLC Ketamine claims longer lasting benefits from its approach, while offering free treatments to veterans.

Therapists See Benefits and Risks in Psychedelic Therapy During Covid-19 Crisis

The pandemic is changing the way psychedelic therapists work with clients. While MDMA-assisted therapy is being suspended, ketamine-assisted therapy is going online.